(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ORI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ORI

ST13

US500000098393638

Class

5

Filing

98393638

Registration

7911163

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/26/2025

Trademark type

Word

Nice classes

5

Filing date

02/06/2024

Registration date

08/26/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/26/2025

Last transaction

08/26/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

London, GB

Examiner

GALBO, AMANDA

Law office

N70

Current location

INTENT TO USE SECTION

Holders and representatives

Holders

Oribiotech Limited

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for use in cell culturingcell culture media for medical or veterinary purposes; chemical preparations for pharmaceutical purposesfor cell and gene therapy; chemical preparations for medical purposesfor cell and gene therapy; biochemical preparations and biological preparations for medical purposes for use in cell culturingcell therapy; biochemical preparations and biological preparations for use in gene therapy; cell growth media for cell culturing for medical and clinical usecell therapy; cell growth media for gene therapy; pharmaceuticalspharmaceutical preparations for use in cell and gene therapy

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/26/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/26/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

08/05/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/24/2025

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

06/13/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/13/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/18/2025

PUBO

PUBLISHED FOR OPPOSITION

03/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/12/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/28/2025

PUBO

PUBLISHED FOR OPPOSITION

01/28/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/22/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/07/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

01/07/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/07/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

01/07/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/07/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/24/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/24/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

11/27/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

11/27/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/31/2024

GNRT

NON-FINAL ACTION E-MAILED

08/31/2024

CNRT

NON-FINAL ACTION WRITTEN

08/31/2024

DOCK

ASSIGNED TO EXAMINER

08/30/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/04/2024

NWAP

NEW APPLICATION ENTERED

02/06/2024

Continuous trademark protection

Get notified about every new filing that threatens ORI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.